Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates

Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates

US Patent 9345785 · Granted May 24, 2016

Estimated economic value: $54,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Periostin antibodies and methods of using the same2025
Universal immune receptor expressed by T cells for the targeting of diverse and 2024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS22022
Anti-NTB-A antibodies and related compositions and methods2022
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2021